EGFR GENE MUTATION
Clinical trials for EGFR GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR GENE MUTATION trials appear
Sign up with your email to follow new studies for EGFR GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in slowing brain metastases from lung cancer
Disease control CompletedThis study tested if a new drug, AZD3759, could control advanced lung cancer that had spread to the brain better than standard drugs. It involved nearly 500 adults with a specific genetic mutation (EGFR+) who had not yet received treatment for their advanced cancer. The main goal…
Matched conditions: EGFR GENE MUTATION
Phase: PHASE2, PHASE3 • Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 21:30 UTC
-
New drug duo tested in fight against tough cancers
Disease control CompletedThis study tested whether combining an experimental drug (sEphB4-HSA) with an approved immunotherapy (pembrolizumab) could help control advanced lung or head/neck cancers that had worsened after standard chemotherapy. It involved 42 patients who received both drugs by IV infusion…
Matched conditions: EGFR GENE MUTATION
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC